Skip to main content
Contact Us
Subscribe
E-Edition
62°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Akebia Therapeutics
(NQ:
AKBA
)
1.120
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 28, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
174
Open
1.120
Bid (Size)
1.080 (3)
Ask (Size)
1.290 (8)
Prev. Close
1.120
Today's Range
1.120 - 1.120
52wk Range
0.2410 - 1.840
Shares Outstanding
174,537,458
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Analyst Highly Confident In Akebia Therapeutics' Kidney Disease-Associated Anemia Drug, Stock Soars
August 28, 2023
HC Wainwright has upgraded Akebia Therapeutics Inc (NASDAQ: AKBA) from Neutral to Buy rat
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 28, 2023
Via
Benzinga
Performance
YTD
+79.92%
+79.92%
1 Month
-27.27%
-27.27%
3 Month
+21.03%
+21.03%
6 Month
+98.86%
+98.86%
1 Year
+239.39%
+239.39%
More News
Read More
Benzinga's Top Ratings Upgrades, Downgrades For August 28, 2023
August 28, 2023
Via
Benzinga
Earnings Outlook For Akebia Therapeutics
August 24, 2023
Via
Benzinga
Where Akebia Therapeutics Stands With Analysts
June 14, 2023
Via
Benzinga
Analyst Ratings for Akebia Therapeutics
May 26, 2023
Via
Benzinga
The Latest Analyst Ratings for Akebia Therapeutics
May 26, 2023
Via
Benzinga
Akebia Therapeutics's Return On Capital Employed Overview
May 22, 2023
Via
Benzinga
Earnings Scheduled For August 25, 2023
August 25, 2023
Via
Benzinga
Intuit, Hibbett And 3 Stocks To Watch Heading Into Friday
August 25, 2023
Via
Benzinga
Fear & Greed Index Moves To 'Fear' Zone Ahead Of Powell's Speech
August 25, 2023
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
12 Health Care Stocks Moving In Tuesday's Intraday Session
July 25, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
July 10, 2023
Via
Benzinga
Earnings Preview: Akebia Therapeutics
May 05, 2023
Via
Benzinga
4 Analysts Have This to Say About Akebia Therapeutics
April 26, 2023
Via
Benzinga
Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 25, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
July 07, 2023
Via
Benzinga
Pocket Change, Big Gains: 3 Penny Stocks Ready to Boom
July 06, 2023
Via
InvestorPlace
Biotech Alert: Searches Spiking For These Stocks Today - Friday, June 2
June 02, 2023
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2023
May 31, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 31, 2023
Via
Benzinga
Why Shares of Akebia Therapeutics Were Up Tuesday
May 23, 2023
Via
The Motley Fool
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
May 22, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 09, 2023
Via
InvestorPlace
Akebia Says Vadadustat Non Inferior To Standard Care In Alternative Dosing Study In Anemia Patients On Dialysis
April 03, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.